Drug Information Analysis Service

Silverberg E Boring C Squires T . Cancer statistics. Atlanta: American Cancer Society, 1990: 9–26.

American Cancer Society. Cancer facts & figures—1990. Atlanta: American Cancer Society, 1990: 2–3.

Buring J Hennekens CH . Current issues in cancer chemoprevention. In: Hakama M Bera V Cullen JW Parkin DM , eds. Evaluating effectiveness of primary prevention of cancer. Leon, France: IARC Scientific Publications, 1990: 185–92.

Peto R Doll R Buckley JD Sporn MB . Can dietary beta-carotene materially reduce human cancer rates? Nature 1981; 290: 201–8.

Chren MM Bickers DR . Dermatological pharmacology. In: Gilman AG Rall TW Nies AS Tayor P , eds. Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press, 1990: 1580.

Mettlin C Graham S . Dietary risk factors in human bladder cancer. Am J Epidemiol 1979; 110: 255–63.

Graham S Dayal H Swanson M Mittelman A . Diet in the epidemiology of cancer of the colon and rectum. J Natl Cancer Inst 1978; 61: 709–14.

Mettlin C Graham S Swanson M . Vitamin A and lung cancer. J Natl Cancer Inst 1979; 62: 1435–8.

Hirayama T . Diet and cancer. Nutr Cancer 1979; 1: 67–81.

Salvini S Hunter DJ Sampson L Stampfer MJ Colditz GA Rosner B . Food-based validation of a dietary questionnaire: The effects of week-to-week variation in food consumption. Int J Epidemiol 1989; 18: 858–67.

Zheng W Blot WJ Diamond EL Norkus EP Spate V Morris JS . Serum micronutrients and the subsequent risk of oral and pharyngeal cancer. Cancer Res 1993; 53: 795–8.

Garewal HS Meyskens FL Killen D Reeves D Kiersch TA Elletson H . Response of oral leukoplakia to beta carotene. J Clin Oncol 1990; 8: 1715–20.

Manson JE Hunter DJ Buring JE Hennekins CH . Beta carotene to prevent skin cancer (letter). N Engl J Med 1991; 324: 923–5.

Greenberg ER Baron JA Stukel TA Stevens MM Mandel JS Spencer SK . A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. N Engl J Med 1990; 323: 789–94.

Malone WF . Antioxidants as chemopreventives. Am J Clin Nutr 1991; 53 (suppl 1):305S–13S.

Gaziano JM Manson JE Ridker PM Buring JE Hennekins CH . Beta carotene therapy for chronic stable angina (abstract). Circulation 1990; 82 (suppl 4):201.

Ben-Amotz AM Shoshana M Edelstein S Avron M . Bioavailability of a natural isomer mixture as compared with synthetic all-trans-beta-carotene in rats and chicks. J Nutr 1989; 119: 1013–9.

Benet LZ Williams RL . Design and optimization of dosage regimens; pharmacokinetic data. In: Gilman AG Rall TW Nies AS Taylor P , eds. Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press, 1990: 1689.

Benet LZ Mitchell JR Sheiner LB . Pharmacokinetics: The dynamics of drug absorption, distribution, and elimination. In: Gilman AG Rail TW Nies AS Taylor P , eds. Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press, 1990: 3–32.

Plenge P Mellerup ET . Lithium and the kidney: Is one daily dose better than two? Compr Psychiatry 1986; 27: 336–42.

Perry PJ Dunner FJ Hahn RL Tsuang MT Berg MJ . Lithium kinetics in single daily dosing. Acta Psychiatr Scand 1981; 64: 281–94.

Lauritsen BJ Mellerup ET Plenge P Rasmussen S Vestergaard P Schou M . Serum lithium concentrations around the clock with different treatment regimens and the diurnal variation of the renal lithium clearance. Acta Psychiatr Scand 1981; 64: 314–9.

Bone S Roose SP Dunner DL Fieve RR . Bioavailability of lithium carbonate: Single versus multiple daily dosing. J Clin Psychopharmacol 1981; 1: 390–1.

Plenge P Mellerup ET Bolwig TG Brun C Hetmar O Ladefoged J . Lithium treatment: Does the kidney prefer one daily dose or two? Acta Psychiatr Scand 1982; 66: 121–8.

Bowen RC Grof P Grof E . Less frequent lithium administration and lower urine volume. Am J Psychiatry 1991; 142: 189–92.

Grebb JA . Psychiatric rating scales. In: Kaplan HI Sadoch BJ , eds. Comprehensive textbook of psychiatry, vol. 1. 5th ed. Baltimore, MD:1989: 534–52.

Bech P Bolwig TG Kramp P . The Bech-Rafaelsen mania scale and the Hamilton depression scale. Acta Psychiatr Scand 1979; 59: 420–30.

Lingjaerde O Ahlfors UG Bech P . The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand 1987; 334 (suppl): 1–100.

Abraham G Delva N Waldron J Lawson JS Owen J . Lithium treatment: A comparison of once- and twice-daily dosing. Acta Psychiatr Scand 1992; 85: 65–9.

Gelenberg AJ Kane JM Keller MB Lavori P Rosenbaum JF Cole K . Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 1989; 321: 1489–93.

Haft RF Kasper DL . Group B Streptococcus infection in mother and child. Hosp Pract 1991; 26 (12):111–34.

Noya FJD Baker CJ . Prevention of group B streptococcal infection. Infect Dis Clin N Am 1992; 6: 41–55.

Hueston WJ . Preventing group B streptococcal infection in newborns. Am Fam Physician 1991; 43: 487–92.

Gardner SE Yow MD Leeds LJ Thompson PK Mason EO Jr Clark DJ . Failure of penicillin to eradicate group B streptococcal colonization in the pregnant woman. A couple study. Am J Obstet Gynecol 1979; 135: 1062–5.

Committee on Infectious Diseases and Committee on Fetus and Newborn, American Academy of Pediatrics Guidelines for prevention of group B streptococcal infection by chemoprophylaxis Pediatrics 1992; 90: 775–8.

Larsen JW Dooley SL . Group B streptococcal infections: An obstetrical viewpoint. Pediatrics 1993; 91: 148–9.

Committee on Technical Bulletins, American College of Obstetricians and Gynecologists. Group B streptococcal infections in pregnancy—ACOG technical bulletin No. 170—July 1992. Int J Gynecol Obstet 1993; 42: 55–9.

Mohle-Boetani JC Schuchat A Plikaytis BD Smith JD Broome CV . Comparison of prevention strategies for neonatal group B streptococcal infection: A population-based economic analysis. JAMA 1993; 270: 1442–8.

Green M Dashefsky B Wald ER Laifer S Harger J Guthrie R . Comparison of two antigen assays for rapid intrapartum detection of vaginal group B streptococcal colonization. J Clin Microbiol 1993; 31: 78–82.

Coleman RT Sherer DM Maniscalco WM . Prevention of neonatal group B streptococcal infections: Advances in maternal vaccine development. Obstet Gynecol 1992; 80: 301–9.

Committee on Issues and Priorities for New Vaccine Development, Institute of Medicine. Prospects for immunizing against Streptococcus group B. In: New vaccine development: Establishing priorities. Vol 1. Diseases of importance in the United States. Washington, DC: National Academy Press, 1985: 424–39.

Baker CJ Rench MA Edwards MS Carpenter RJ Hays BM Kasper DL . Immunization of pregnant women with a polysaccharide vaccine of group B Streptococcus. N Engl J Med 1988; 319: 1180–5.

Paoletti LC Kasper DL Michon F DiFabio J Holme K Jennings HJ . An oligosaccharide-tetanus toxoid conjugate vaccine against type III group B Streptococcus. J Biol Chem 1990; 265: 18278–83.

Wessels MR Paoletti LC Kasper DL DiFabio JL Michon F Holme K . Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus. J Clin Invest 1990; 86: 1428–33.

Stalhammar-Carlemalm M Stenberg L Lindahl G . Protein Rib: A novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections. J Exp Med 1993; 177: 1593–603.

Raff HV Siscoe PJ Wolff EA Maloney G Shuford W . Human monoclonal antibodies to group B Streptococcus. Reactivity and in vivo protection against multiple serotypes. J Exp Med 1988; 168: 905–17.

Kresch MJ Gross I . The biochemistry of fetal lung development. Clin Perinatol 1987; 14: 481–507.

Coustan DR . Clinical aspects of antenatal enhancement of pulmonary maturation. Clin Perinatol 1987; 14: 697–710.

Liggens GC Howie RN . A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972; 50: 515–24.

Block MF Kling OR Crosby WM . Antenatal glucocorticoid therapy for the prevention of respiratory distress syndrome in the premature infant. Obstet Gynecol 1976; 50: 186–90.

Papageorgiou AN Desgranges MF Masson M Colle E Shatz R Gelfand M . The antenatal use of betamethasone in the prevention of respiratory distress syndrome: A controlled double blind study. Pediatrics 1979; 63: 73–9.

Doran TA Swyer P MacMurray B Malum W Enhorning G Bernstein A . Results of a double-blind controlled study on the use of betamethasone in the prevention of respiratory distress syndrome. Am J Obstet Gynecol 1980; 136: 313–20.

Schmidt PL Sims ME Strassner HT Paul RH Mueller E McCart D . Effect of antepartum glucocorticoid administration upon neonatal respiratory distress syndrome and perinatal infection. Am J Obstet Gynecol 1984; 148: 178–86.

Gamsu HR Mullinger BM Donnai P Dash CH . Antenatal administration of betamethasone to prevent respiratory distress syndrome in preterm infants: Report of a UK multicentre trial. Br J Obstet Gynecol 1989; 96: 401–10.

Edelstein E , ed. American druggist blue book. New York: Hearst Corporation, 1993.

Farrell EE Silver RK Kimberlin LV Wolf ES Dusik JM . Impact of antenatal dexamethasone administration on respiratory distress syndrome in surfactant-treated infants. Am J Obstet Gynecol 1989; 161: 628–33.

Morales WJ Diebel D Lazar AJ Zadrozny D . The effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome in preterm gestations with premature rupture of membranes. Am J Obstet Gynecol 1986; 154: 591–5.

Collaborative Group on Antenatal Steroid Therapy Effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome Am J Obstet Gynecol 1981; 141: 276–87.

Ballard PL Ballard RA Granberg JP Sniderman S Gluckman PD Kaplan SL . Fetal sex and prenatal betamethasone therapy. J Pediatr 1980; 97: 451–4.

Guerrini P Vesce F Colla F Travagli S Cocilovo G . Contribution to the assessment of steroid therapy in the prevention of respiratory distress syndrome in the neonate. Clin Exp Obstet Gynecol 1990; 17: 145–9.

Taeusch HW Frigoletto F Kitzmiller J Avery M Hehre A Fromm B . Risk of respiratory distress syndrome after prenatal dexamethasone treatment. Pediatrics 1979; 63: 64–72.

Capsi E Schreyer P Weinraub Z Reif R Levi I Mundel G . Prevention of the respiratory distress syndrome in premature infants by antepartum glucocorticoid therapy. Br J Obstet Gynecol 1976; 83: 187–93.

Young BK Klein SA Katz M Wilson SJ Douglas GW . Intravenous dexamethasone for prevention of neonatal respiratory distress: A prospective controlled study. Am J Obstet Gynecol 1980; 138: 203–9.